146 related articles for article (PubMed ID: 32666411)
1. Dicationic Amino Substituted Gemini Surfactants and their Nanoplexes: Improved Synthesis and Characterization of Transfection Efficiency and Corneal Penetration In Vitro.
Narsineni L; Foldvari M
Pharm Res; 2020 Jul; 37(7):144. PubMed ID: 32666411
[TBL] [Abstract][Full Text] [Related]
2. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
Mohammed-Saeid W; Michel D; El-Aneed A; Verrall RE; Low NH; Badea I
J Pharm Pharm Sci; 2012; 15(4):548-67. PubMed ID: 23106958
[TBL] [Abstract][Full Text] [Related]
3. A flow cytometric approach to study the mechanism of gene delivery to cells by gemini-lipid nanoparticles: an implication for cell membrane nanoporation.
Gharagozloo M; Rafiee A; Chen DW; Foldvari M
J Nanobiotechnology; 2015 Sep; 13():62. PubMed ID: 26415935
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.
Singh J; Michel D; Chitanda JM; Verrall RE; Badea I
J Nanobiotechnology; 2012 Feb; 10():7. PubMed ID: 22296763
[TBL] [Abstract][Full Text] [Related]
5. BDNF gene delivery to the retina by cell adhesion peptide-conjugated gemini nanoplexes in vivo.
Narsineni L; Chen DW; Foldvari M
J Control Release; 2023 Jul; 359():244-256. PubMed ID: 37257566
[TBL] [Abstract][Full Text] [Related]
6. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
[TBL] [Abstract][Full Text] [Related]
7. Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles.
Wettig SD; Badea I; Donkuru M; Verrall RE; Foldvari M
J Gene Med; 2007 Aug; 9(8):649-58. PubMed ID: 17654656
[TBL] [Abstract][Full Text] [Related]
8. Cellular Uptake and Distribution of Gemini Surfactant Nanoparticles Used as Gene Delivery Agents.
Jin W; Al-Dulaymi M; Badea I; Leary SC; Rehman J; El-Aneed A
AAPS J; 2019 Aug; 21(5):98. PubMed ID: 31388860
[TBL] [Abstract][Full Text] [Related]
9. Design and Evaluation of RGD-Modified Gemini Surfactant-Based Lipoplexes for Targeted Gene Therapy in Melanoma Model.
Mohammed-Saeid W; Chitanda J; Al-Dulaymi M; Verrall R; Badea I
Pharm Res; 2017 Sep; 34(9):1886-1896. PubMed ID: 28643235
[TBL] [Abstract][Full Text] [Related]
10. Tuning optimum transfection of gemini surfactant-phospholipid-DNA nanoparticles by validated theoretical modeling.
Taheri-Araghi S; Chen DW; Kohandel M; Sivaloganathan S; Foldvari M
Nanoscale; 2019 Jan; 11(3):1037-1046. PubMed ID: 30569915
[TBL] [Abstract][Full Text] [Related]
11. Modulation of pyridinium cationic lipid-DNA complex properties by pyridinium gemini surfactants and its impact on lipoplex transfection properties.
Sharma VD; Lees J; Hoffman NE; Brailoiu E; Madesh M; Wunder SL; Ilies MA
Mol Pharm; 2014 Feb; 11(2):545-59. PubMed ID: 24377350
[TBL] [Abstract][Full Text] [Related]
12. Mixed aggregate formation in gemini surfactant/1,2-dialkyl-sn-glycero-3-phosphoethanolamine systems.
Akbar J; Tavakoli N; Marangoni DG; Wettig SD
J Colloid Interface Sci; 2012 Jul; 377(1):237-43. PubMed ID: 22515995
[TBL] [Abstract][Full Text] [Related]
13. Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents.
Singh J; Yang P; Michel D; Verrall RE; Foldvari M; Badea I
Curr Drug Deliv; 2011 May; 8(3):299-306. PubMed ID: 21291379
[TBL] [Abstract][Full Text] [Related]
14. Transfection of plasmid DNA by nanocarriers containing a gemini cationic lipid with an aromatic spacer or its monomeric counterpart.
Martínez-Negro M; Barrán-Berdón AL; Aicart-Ramos C; Moyá ML; de Ilarduya CT; Aicart E; Junquera E
Colloids Surf B Biointerfaces; 2018 Jan; 161():519-527. PubMed ID: 29128838
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic and aggregation properties of aza- and imino-substituted gemini surfactants designed for gene delivery.
Wettig SD; Wang C; Verrall RE; Foldvari M
Phys Chem Chem Phys; 2007 Feb; 9(7):871-7. PubMed ID: 17287881
[TBL] [Abstract][Full Text] [Related]
16. Di-Peptide-Modified Gemini Surfactants as Gene Delivery Vectors: Exploring the Role of the Alkyl Tail in Their Physicochemical Behavior and Biological Activity.
Al-Dulaymi MA; Chitanda JM; Mohammed-Saeid W; Araghi HY; Verrall RE; Grochulski P; Badea I
AAPS J; 2016 Sep; 18(5):1168-1181. PubMed ID: 27184577
[TBL] [Abstract][Full Text] [Related]
17. In vivo cutaneous interferon-gamma gene delivery using novel dicationic (gemini) surfactant-plasmid complexes.
Badea I; Verrall R; Baca-Estrada M; Tikoo S; Rosenberg A; Kumar P; Foldvari M
J Gene Med; 2005 Sep; 7(9):1200-14. PubMed ID: 15895387
[TBL] [Abstract][Full Text] [Related]
18. Gemini surfactant dimethylene-1,2-bis(tetradecyldimethylammonium bromide)-based gene vectors: a biophysical approach to transfection efficiency.
Cardoso AM; Faneca H; Almeida JA; Pais AA; Marques EF; de Lima MC; Jurado AS
Biochim Biophys Acta; 2011 Jan; 1808(1):341-51. PubMed ID: 20937247
[TBL] [Abstract][Full Text] [Related]
19. DNA-DOPE-gemini surfactants complexes at low surface charge density: from structure to transfection efficiency.
Hubčík L; Galliková D; Pullmannová P; Lacinová Ľ; Sulová Z; Hanulová M; Funari SS; Devínsky F; Uhríková D
Gen Physiol Biophys; 2018 Jan; 37(1):57-69. PubMed ID: 29424352
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and aggregation properties of dissymmetric phytanyl-gemini surfactants for use as improved DNA transfection vectors.
Wang H; Wettig SD
Phys Chem Chem Phys; 2011 Jan; 13(2):637-42. PubMed ID: 20981388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
